Haemonetics (HAE) EBT Margin (2009 - 2026)

Haemonetics has reported EBT Margin for 18 years, with the latest figure at 14.02% in Q2 2026.

• On a quarterly basis, EBT Margin fell 4.0% year-over-year to 14.02% in Q2 2026; TTM through Jun 2026 was 9.65%, a 599.0% decrease from a year earlier, with the FY2026 full-year figure at 9.6%, down 599.0% from the prior year.
• EBT Margin was 14.02% for Q2 2026 at Haemonetics, up from 8.2% in the prior quarter.
• The five-year high for EBT Margin was 21.4% in Q1 2025, with the low at 8.2% in Q1 2026.
• Average EBT Margin over 5 years is 12.03%, with a median of 13.8% recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: EBT Margin surged 1796 bps in 2022, then tumbled 2960 bps in 2026.
• Over 5 years, EBT Margin stood at 13.83% in 2022, then dropped by 5 bps to 13.09% in 2023, then rose by 9 bps to 14.32% in 2024, then gained by 24 bps to 17.69% in 2025, then declined by 21 bps to 14.02% in 2026.
• The last three EBT Margin figures came in at 14.02% (Q2 2026), 8.2% (Q1 2026), and 17.69% (Q4 2025), per Business Quant data.